Addressing concerns regarding associated costs, transparency, and integrity of research in recent stem cell trial

[...]we went to great effort to ensure that the treatments were completely funded by the sponsor. All meetings for the preparation of this article were approached with utmost objectivity, from a research perspective, and with no “direct-to-consumer marketing and sale of putative stem cell treatments...

Full description

Saved in:
Bibliographic Details
Published in:Stem cells translational medicine 2021-12, Vol.10 (12), p.1715-1716
Main Authors: Riordan, Neil H., Paz Rodríguez, Jorge
Format: Article
Language:English
Subjects:
Adverse events
Autism
Bioethics
Costs
Letter to the Editor
Medical personnel
Peer review
Research funding
Stem cell research
Stem cells
Umbilical cord
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:[...]we went to great effort to ensure that the treatments were completely funded by the sponsor. All meetings for the preparation of this article were approached with utmost objectivity, from a research perspective, and with no “direct-to-consumer marketing and sale of putative stem cell treatments and (…) a financial interest in continuing to sell such products” 2 ulterior motives. [...]there was no bias in classifying adverse events as “related to treatment”—some of the events recorded (1) are as benign as ant or mosquito bites and rashes, (2) respond to clinical issues noted prior to treatment, or (3) were deemed to be unrelated to treatment by licensed medical professionals. [...]our study conclusions were well supported by the data.
ISSN:2157-6564
2157-6580
2157-6580
DOI:10.1002/sctm.21-0234